Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenqu Xiaoshi oral liquid for pediatric functional dyspepsia
ChiCTR1900022654Phase 4Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of shen qu xiao shi oral liquid and domperidone in functional dyspepsia (FD) (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Total effective rate. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
shen qu xiao shi oral liquiddomperidone
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR1900022654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022654.